Chris Davis Viatris Inc Transaction History
Davis Selected Advisers
- $17.8 Billion
- Q1 2024
A detailed history of Chris Davis (Davis Selected Advisers) transactions in Viatris Inc stock. As of the latest transaction made, Davis Selected Advisers holds 57,465,399 shares of VTRS stock, worth $609 Million. This represents 3.85% of its overall portfolio holdings.
Number of Shares
57,465,399
Previous 57,465,399
-0.0%
Holding current value
$609 Million
Previous $686 Million
-0.0%
% of portfolio
3.85%
Previous 3.85%
Shares
14 transactions
Others Institutions Holding VTRS
# of Institutions
1,094Shares Held
945MCall Options Held
3.49MPut Options Held
2.6M-
Vanguard Group Inc Valley Forge, PA142MShares$1.5 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY93.3MShares$989 Million0.03% of portfolio
-
State Street Corp Boston, MA62.8MShares$665 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD57.9MShares$614 Million0.08% of portfolio
-
Invesco Ltd. Atlanta, GA31.2MShares$331 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.9B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...